Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-9.38	-10.83	-11.48	-13.29	-8.79	-8.91
Depreciation & Amortization	0.17	0.18	0.19	0.19	0.18	0.18
Share-Based Compensation	0.22	0.3	0.41	0.48	0.14	0.3
Other Operating Activities	-1.07	-0.41	-1.26	0.76	-0.33	-0.21
Operating Cash Flow	-10.05	-10.75	-12.13	-11.86	-8.8	-8.65
Capital Expenditures	-0.01	-0.01	-0.12	-0.05	-0.02	-0.07
Investing Cash Flow	-0.01	-0.01	-0.12	-0.05	-0.02	-0.07
Share Issuance / Repurchase	7.45	7.44	0	21.72	15.93	0.78
Debt Issued / Paid	0	0	0	0	0.2	-0.01
Other Financing Activities	-0.01	-0.03	-0.03	-0	-0	-0
Financing Cash Flow	7.45	7.41	-0.03	21.72	16.13	0.77
Net Cash Flow	-2.61	-3.34	-12.28	9.81	7.31	-7.95
Free Cash Flow	-10.06	-10.75	-12.25	-11.91	-8.82	-8.72
Free Cash Flow Margin	-	-	-	-	-	-41509.52%
Free Cash Flow Per Share	-19.76	-46.45	-97.00	-100.24	-207.67	-2043.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).